These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 24350587)
1. Streptococcus pneumoniae serotype distribution in children in the Russian Federation before the introduction of pneumococcal conjugate vaccines into the National Immunization Program. Tatochenko V; Sidorenko S; Namazova-Baranova L; Mayanskiy N; Kulichenko T; Baranov A; Lobzin Y; Kharit S; Kozlov R; Andreeva I; Muravjev A; Chagaryan A; Koroleva I; Beloshitskiy G; Mironov K; Degtyareva E; Reinert RR Expert Rev Vaccines; 2014 Feb; 13(2):257-64. PubMed ID: 24350587 [TBL] [Abstract][Full Text] [Related]
2. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait. Mokaddas E; Albert MJ Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356 [TBL] [Abstract][Full Text] [Related]
3. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA). Shibl AM; Memish ZA; Al-Kattan KM Vaccine; 2012 Dec; 30 Suppl 6():G32-6. PubMed ID: 23228355 [TBL] [Abstract][Full Text] [Related]
4. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Isaacman DJ; McIntosh ED; Reinert RR Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359 [TBL] [Abstract][Full Text] [Related]
5. Streptococcus pneumoniae serotype distribution in Vojvodina before the introduction of pneumococcal conjugate vaccines into the National Immunization Program. Petrović V; Šeguljev Z; Ristić M; Djekić-Malbaša J; Radosavljević B; Medić D; Mihajlović-Ukropina M; Hadnadjev M; Gajic I; Opavski N Srp Arh Celok Lek; 2016; 144(9-10):521-6. PubMed ID: 29653038 [TBL] [Abstract][Full Text] [Related]
6. Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines. Rodgers GL; Arguedas A; Cohen R; Dagan R Vaccine; 2009 Jun; 27(29):3802-10. PubMed ID: 19446378 [TBL] [Abstract][Full Text] [Related]
7. Dynamics of pneumococcal carriage among day-care center attendees during the transition from the 7-valent to the higher-valent pneumococcal conjugate vaccines in Greece. Grivea IN; Priftis KN; Giotas A; Kotzia D; Tsantouli AG; Douros K; Michoula AN; Syrogiannopoulos GA Vaccine; 2014 Nov; 32(48):6513-20. PubMed ID: 25252194 [TBL] [Abstract][Full Text] [Related]
8. Serotypes and antibiotic resistance of non-invasive Streptococcus pneumoniae circulating in pediatric hospitals in Moscow, Russia. Mayanskiy N; Alyabieva N; Ponomarenko O; Lazareva A; Katosova L; Ivanenko A; Kulichenko T; Namazova-Baranova L; Baranov A Int J Infect Dis; 2014 Mar; 20():58-62. PubMed ID: 24462930 [TBL] [Abstract][Full Text] [Related]
9. The impact of pneumococcal conjugate vaccines on serotype 19A nasopharyngeal carriage. Tin Tin Htar M; Sings HL; Syrochkina M; Taysi B; Hilton B; Schmitt HJ; Gessner BD; Jodar L Expert Rev Vaccines; 2019 Dec; 18(12):1243-1270. PubMed ID: 31587592 [No Abstract] [Full Text] [Related]
10. Nasopharyngeal pneumococcal carriage in healthy Turkish children after 13-valent conjugated pneumococcal vaccine implementation in the national immunization program. Kanık Yüksek S; Tezer H; Gülhan B; Özkaya Parlakay A; Güldemir D; Coskun-Ari FF; Bedir Demirdağ T; Kara Uzun A; Kızılgün M; Solmaz S; Kılıç S; Yalınay Çırak M; Baran Aksakal FN J Infect Public Health; 2020 Feb; 13(2):266-274. PubMed ID: 31818710 [TBL] [Abstract][Full Text] [Related]
11. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era. Zuccotti G; Mameli C; Daprai L; Garlaschi ML; Dilillo D; Bedogni G; Faccini M; Gramegna M; Torresani E; ; Ballerini E; Benincaso A; Bonvissuto M; Bricalli D; Brioschi M; Calloni CS; Camiletti MI; Colella G; De Angelis L; Decarlis S; Di Nello F; Dozzi M; Galli E; Gandini V; Giuliani MG; Laviola F; Loda B; Macedoni M; Mazzucchi E; Metta MG; Moscatiello A; Nannini P; Petruzzi M; Picicco D; Picciotti M; Pisanelli S; Porta N; Ramponi G; Redaelli F; Rubini R; Sala N; Saitta V; Scelza G; Tiso RM; Tomasetto M; Torcoletti M; Travaini M; Valentini M; Vessia C Vaccine; 2014 Jan; 32(5):527-34. PubMed ID: 24342249 [TBL] [Abstract][Full Text] [Related]
12. Non-susceptibility trends and serotype coverage by conjugate pneumococcal vaccines in a Tunisian paediatric population: a 10-year study. Charfi F; Smaoui H; Kechrid A Vaccine; 2012 Dec; 30 Suppl 6():G18-24. PubMed ID: 23228353 [TBL] [Abstract][Full Text] [Related]
13. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines. Shouval DS; Greenberg D; Givon-Lavi N; Porat N; Dagan R Pediatr Infect Dis J; 2009 Apr; 28(4):277-82. PubMed ID: 19258924 [TBL] [Abstract][Full Text] [Related]
14. Pneumococcal acute otitis media in infants and children in central Romania, 2009-2011: microbiological characteristics and potential coverage by pneumococcal conjugate vaccines. Falup-Pecurariu O; Leibovitz E; Mercas A; Bleotu L; Zavarache C; Porat N; Dagan R; Greenberg D Int J Infect Dis; 2013 Sep; 17(9):e702-6. PubMed ID: 23522635 [TBL] [Abstract][Full Text] [Related]
15. Serotype distribution of Streptococcus pneumoniae and potential impact of pneumococcal conjugate vaccines in China: A systematic review and meta-analysis. Chen K; Zhang X; Shan W; Zhao G; Zhang T Hum Vaccin Immunother; 2018 Jun; 14(6):1453-1463. PubMed ID: 29451838 [TBL] [Abstract][Full Text] [Related]
16. Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children. Tocheva AS; Jefferies JM; Rubery H; Bennett J; Afimeke G; Garland J; Christodoulides M; Faust SN; Clarke SC Vaccine; 2011 Jun; 29(26):4400-4. PubMed ID: 21504773 [TBL] [Abstract][Full Text] [Related]
17. Modeling the decline in pneumococcal acute otitis media following the introduction of pneumococcal conjugate vaccines in the US. Shea KM; Weycker D; Stevenson AE; Strutton DR; Pelton SI Vaccine; 2011 Oct; 29(45):8042-8. PubMed ID: 21871518 [TBL] [Abstract][Full Text] [Related]
18. Carriage of Streptoccoccus pneumoniae 7 years after implementation of vaccination program in a population with very high and long-lasting coverage, Italy. Ansaldi F; de Florentiis D; Canepa P; Zancolli M; Martini M; Orsi A; Durando P; Icardi G Vaccine; 2012 Mar; 30(13):2288-94. PubMed ID: 22306795 [TBL] [Abstract][Full Text] [Related]
19. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae. Dagan R Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():16-20. PubMed ID: 19366365 [TBL] [Abstract][Full Text] [Related]
20. Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon. Hanna-Wakim R; Chehab H; Mahfouz I; Nassar F; Baroud M; Shehab M; Pimentel G; Wasfy M; House B; Araj G; Matar G; Dbaibo G; Vaccine; 2012 Dec; 30 Suppl 6():G11-7. PubMed ID: 23228352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]